Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may spot lingering lung cancer earlier

NCT ID NCT07257458

Recruiting now Knowledge-focused Sponsor: Beijing Haidian Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a blood test that checks for specific DNA changes (methylation) can find leftover cancer cells after lung cancer surgery. About 30 people with non-small cell lung cancer will give blood samples before and after surgery for up to two years. The goal is to see if this test can predict if the cancer will come back earlier than standard methods, which could help doctors personalize follow-up care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER (NSCLC)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Haidian Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100080, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••